Institutional Ownership
Thermo Fisher Scientific Inc
CUSIP 883556102COMTMOQ1 2026
Latest EPS (Diluted)
$4.68
Q2 2026 · Jun 30, 2026
Latest Revenue
$11.99B
Reported quarter
Latest Net Income
$1.74B
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Q2 2026 | $4.68 | $4.68 | $11.99B | $1.74B | 10-Q |
| Mar 31, 2026 | Q1 2026 | $4.44 | $4.43 | $11.01B | $1.65B | 10-Q |
| Sep 30, 2025 | Q3 2025 | $4.28 | $4.27 | $11.12B | $1.62B | 10-Q |
| Jun 30, 2025 | Q2 2025 | $4.28 | $4.28 | $10.86B | $1.62B | 10-Q |
| Mar 31, 2025 | Q1 2025 | $3.99 | $3.98 | $10.36B | $1.51B | 10-Q |
| Sep 30, 2024 | Q3 2024 | $4.26 | $4.25 | $10.60B | $1.63B | 10-Q |
| Jun 30, 2024 | Q2 2024 | $4.05 | $4.04 | $10.54B | $1.55B | 10-Q |
| Mar 31, 2024 | Q1 2024 | $3.47 | $3.46 | $10.35B | — | 10-Q |
| Sep 30, 2023 | Q3 2023 | $4.44 | $4.42 | $10.57B | — | 10-Q |
| Jun 30, 2023 | Q2 2023 | $3.53 | $3.51 | $10.69B | — | 10-Q |
| Mar 31, 2023 | Q1 2023 | $3.34 | $3.32 | $10.71B | — | 10-Q |
| Sep 30, 2022 | Q3 2022 | $3.82 | $3.79 | $10.68B | — | 10-Q |